Morepen Laboratories declines on reporting 29% fall in Q4 consolidated net profit

13 May 2025 Evaluate

Morepen Laboratories is currently trading at Rs. 59.90, down by 0.48 points or 0.79% from its previous closing of Rs. 60.38 on the BSE.

The scrip opened at Rs. 59.21 and has touched a high and low of Rs. 61.50 and Rs. 57.83 respectively. So far 790154 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 100.80 on 10-Sep-2024 and a 52 week low of Rs. 41.66 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 61.50 and Rs. 54.90 respectively. The current market cap of the company is Rs. 3287.72 crore.

The promoters holding in the company stood at 35.65%, while Institutions and Non-Institutions held 3.62% and 60.72% respectively.

Morepen Laboratories has reported 70.20% fall in its net profit at Rs 11.91 crore for the fourth quarter ended March 31, 2025 as compared to Rs 39.96 crore for the same quarter in the previous year. The total income of the company decreased by 2.90% at Rs 385.08 crore for Q4FY25 as compared Rs 396.59 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 29.33% fall in its net profit at Rs 20.31 crore for fourth quarter ended March 31, 2025 as compared to Rs 28.74 crore for the same quarter in the previous year. However, total income of the company increased by 10.10% at Rs 470.46 crore for Q4FY25 as compared Rs 427.32 crore for the corresponding quarter previous year.

For the year ended March 31, 2025, the company has reported 8.44% fall in its net profit at Rs 101.58 crore as compared to Rs 110.94 crore for the previous year. However, total income of the company increased marginally by 1.30% at Rs 1570.25 crore for year under review as compared to Rs 1550.16 crore for year ended March 31, 2024.

For the year ended March 31, 2025, on the consolidated basis, the company has reported 22.15% rise in its net profit at Rs 118.02 crore as compared to Rs 96.62 crore for the previous year. The total income of the company increased by 7.37% at Rs 1829.94 crore for year under review as compared to Rs 1704.40 crore for year ended March 31, 2024.

Morepen Laboratories Share Price

42.42 -1.03 (-2.37%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×